DRVN drops into its July 28 earnings report with a curious split: the stock fell 11% on the week to $13.61, yet short sellers have been quietly covering rather than pressing their bets, leaving the setup more ambiguous than the price action alone suggests.
The short interest picture is the key contradiction here. Bears have been pulling back — short interest has fallen roughly 16% over the past month, from around 10 million shares in early July to 8.45 million now, bringing SI down to 5.1% of the free float. That is a meaningful reduction, not a rounding error. Availability in the lending market is also far from tight, running at 312% — meaning there are roughly three shares available to borrow for every one already short — well above the 52-week tightest reading of 135%. Cost to borrow remains trivial at 0.57%, barely changed over the week. The borrow market is not pricing in any kind of squeeze dynamic heading into the print.
Options positioning tells a similarly calm story. The put/call ratio is an unusually low 0.0044 — just fractionally above its 20-day average of 0.0040, and only 1.2 standard deviations from that mean. The 52-week range runs as high as 2.44, which makes today's reading look like almost no hedging activity at all. Either the options market is not using puts to express downside risk here, or the float structure simply does not lend itself to meaningful put volume. Either way, there is no sign of defensive positioning building ahead of earnings.
The Street is cautious but not bearish. Analyst data is about 39 days old at this point — the most recent round of target adjustments followed the May earnings miss. After that print sent the stock down 8.8% in a day, most of the covering analysts trimmed targets while holding ratings: Morgan Stanley cut to $16, RBC to $18, BTIG to $17, BMO to $14. The mean target now sits at $17.01, implying roughly 25% upside from the current $13.61. That gap is a double-edged framing — the bulls argue deep value given the Take 5 business's structural growth in oil changes and maintenance; the bears point to accounting restatements, a heavy debt load, and mounting EV adoption risk over the medium term. The EV/EBITDA multiple of 10.3x has edged down modestly over 30 days as the stock has lagged, while the P/E of 10x remains undemanding for the franchise model. The ORTEX short score of 54 — middling, not extreme — corroborates that positioning is neither crowded nor particularly clean.
Institutional flows add one interesting data point. FMR (Fidelity) reported adding 2.76 million shares as of June 30, lifting its stake to 8.24 million shares, making it the largest disclosed holder. ADW Capital and Rubric Capital each initiated new positions in Q1. Against that, Baron Capital trimmed 500,000 shares. The net picture is of active managers selectively building, though the filing dates are largely Q1 and the stock has moved considerably since.
The earnings history is short but pointed: the May print produced an 8.8% single-day drop and a further 3.8% decline over the following five days. The June event was far milder at just 0.8% the next day, though that too drifted lower by week's end. With the next event slated for Monday July 28 at market close, the focus will be on whether the Take 5 segment can sustain the unit economics that bulls rely on for their recovery thesis, and how management characterizes the pace of debt reduction given the balance sheet concerns that have consistently weighed on the multiple.
See the live data behind this article on ORTEX.
Open DRVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
